- Dr. Al-Holou speaking on: Subclonal Evolution of Resistant Cells in Glioblastoma: Identification and Therapeutic Implications
- Dr. Wahl speaking on: Linking altered GBM metabolism to treatment resistance in the lab and clinic
Tuesday, January 18, 2022
DT/TACR Combined Meeting
12:00 PM to 1:00 PM
Zoom meeting
Contact Darla Kroft.
Daniel Wahl, MD, PhD and Wajd Al-Holou, MD